SightfileU.S. market data from official filings
Companies › OCS
OCULIS HOLDING AG (OCS)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001953530 · EDGAR filings · Updated 2026-06-25
OCULIS HOLDING AG (OCS) has 57 institutional managers reporting positions valued at $534.7M per the latest 13F reporting period.
Institutional managers
57
Reported 13F value
$534.7M
Latest updates
- 2026-06-25 — Foreign issuer report (6-K) filed
- 2026-06-01 — Foreign issuer report (6-K) filed
- 2026-05-14 — Foreign issuer report (6-K) filed
- 2026-05-11 — Foreign issuer report (6-K) filed
- 2026-04-29 — SCHEDULE 13G/A filed
- 2026-04-21 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, OCULIS HOLDING AG has 57 institutional holders.
Related companies
CERIBELL INC (CBLL) · PERSONALIS INC (PSNL) · EMBECTA CORP (EMBC) · KAMADA LTD (KMDA) · ZAI LAB LTD (ZLAB) · MYRIAD GENETICS INC (MYGN)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-25.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-25.